Jeewon’s practice focuses on mergers & acquisitions and other complex corporate transactions. She represents public and private companies across a wide variety of industries in connection with corporate transactions and has advised clients on general corporate matters.
Longboard Pharmaceuticals Announces $2.6 Billion Sale to Lundbeck
October 14, 2024
Cooley advised Longboard Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, on its $2.6 billion sale to Lundbeck.
Personalis Announces Expanded Collaboration With Tempus AI
August 16, 2024
Cooley advised Personalis, a company transforming the active management of cancer through breakthrough personalized testing, on its expanded commercial relationship with Tempus AI, including an equity investment by Tempus into Personalis.
Summer Fridays Announces Strategic Investment From TSG Consumer Partners
July 25, 2024
Cooley advised Summer Fridays – a clean, premium skincare and hybrid makeup brand – on its strategic growth investment from TSG Consumer Partners, a top private equity firm.
Cooley advised Tenable Holdings, the exposure management company, on its definitive agreement to acquire Eureka Security, a provider of data security posture management (DSPM) for cloud environments.
Everbridge Enters Into Definitive Agreement to Be Acquired by Thoma Bravo for $1.8 Billion
March 1, 2024
Cooley advised Everbridge, a global leader in critical event management and national public warning solutions, on its definitive agreement to be acquired by Thoma Bravo in an all-cash transaction valuing Everbridge at approximately $1.8 billion.
